Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | — | 4 | — | — | 1 | 5 |
Infections | D007239 | EFO_0000544 | — | — | 1 | — | — | — | 1 |
Drug common name | EMIVIRINE |
INN | emivirine |
Description | Emivirine is a pyrimidone that is uracil which is substituted at positions 1, 5 and 6 by ethoxymethyl, isopropyl, and benzyl groups, respectively. A non-nucleoside inhibitor of HIV-1 reverse transcriptase, emivirine was an unsuccessful experimental agent for the treatment of HIV. It has a role as a HIV-1 reverse transcriptase inhibitor and an antiviral drug. It is functionally related to a uracil. |
Classification | Small molecule |
Drug class | antivirals: non-nucleoside reverse transcriptase inhibitors, not benzoxazinone derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)[nH]c1=O |
PDB | — |
CAS-ID | 149950-60-7 |
RxCUI | — |
ChEMBL ID | CHEMBL35033 |
ChEBI ID | 44143 |
PubChem CID | 65013 |
DrugBank | — |
UNII ID | X87G8IX72O (ChemIDplus, GSRS) |